DFG Research Unit FOR5621
Stylianos Michalakis is Spokesperson of the DFG-funded Research Unit FOR5621 - Ocular Gene Therapy (OCU-GT): Addressing the Unmet Needs in Ocular Gene Therapy.
OCU-GT was launched in 2024 and brings together leading researchers from diverse but complementary fields who are working together to advance the field of ocular gene therapy.
More info can be found at www.for5621.de.